Clinical trial
A Randomised, Double-blinded, Cross-over, Placebo- Controlled Pilot Study to Investigate the Effect of Tomato Extract on TMAO in Overweight or Obese Adults
NCT04160481 is registered in ClinicalTrials.gov with dsm-firmenich Switzerland AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double-blinded, Cross-over, Placebo- Controlled Pilot Study to Investigate the Effect of Tomato Extract on TMAO in Overweight or Obese Adults
- Lead sponsor
- dsm-firmenich Switzerland AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 12, 2019
- Completion date
- March 13, 2020
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular risk factor